Display Settings:

Format

Send to:

Choose Destination
Arch Dermatol. 2007 Mar;143(3):405-6.

What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?

Author information

  • 1Istituto Dermopatico dell'Immacolata, Rome, Italy. r.corona@idi.it

Comment on

PMID:
17372107
[PubMed]

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk